EMPERRA® submitted the Digital Diabetes Management Platform ESYSTA® for approval as DiGA (DTx) to the German BfArM
Emperra has submitted ESYSTA for permanent listing as a Digital Health Application (DTx) to the Federal Institute for Drugs and Medical Devices (BfArM Germany) POTSDAM, BRANDENBURG, GERMANY, October 6, 2024 /EINPresswire.com/ -- EMPERRA® E- …